NR3C1 and acute lymphoblastic leukemia: In conclusion, our study provides compelling evidence that targeting SUMOylation can potentially enhance therapeutic action of glucocorticoids in ALL by modifying GR chromatin occupancy and its interaction with transcriptional networks.